Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy
Authors:
- Lise CuzinLCLise Cuzin
- Pascal PugliesePPPascal Pugliese
- Karine SaunéKSKarine Sauné
- Clotilde AllavenaCAClotilde Allavena
- Jade GhosnJGJade Ghosn
- Jacqueline CottalordaJCJacqueline Cottalorda
- Audrey RodallecARAudrey Rodallec
- Marie Laure ChaixMCMarie Laure Chaix
- Samira Fafi-KremerSFSamira Fafi-Kremer
- Cathia SouliéCSCathia Soulié
- Marlène OukaMOMarlène Ouka
- Charlotte CharpentierCCCharlotte Charpentier
- 24 August 2015
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 29 (13) , 1665-1671
Abstract
The objective of this study is to study factors associated with HIV-DNA levels in chronically infected patients on long-term suppressive antiretroviral therapy (ART). A cross-sectional, multicentre study of patients receiving ART for more than 3 years, HIV-RNA less than 50 copies/ml for more than 2 years and CD4 cell count more than 350 cells/μl. Factors associated with low (1000), compared with intermediate (150-1000 copies/10 PBMCs) levels of HIV-DNA were investigated using multinomial logistic regression. Five hundred and twenty-two patients who initiated ART during the chronic phase were included (71% male; median peak HIV-RNA: 4.88 log10 copies/ml, CD4 cell count nadir: 222 cells/μl). Median ART duration was 13 years [interquartile range (IQR) 7-17], viral suppression was 5.7 years (IQR 3.9-8.5) and 66% of the patients never experienced ART failure. Median HIV-DNA was 323 copies/10 PBMCs (IQR, 129-717) with low, intermediate and high levels observed in 28.3, 55.4 and 16.3%, respectively. In multivariable analysis, women were more likely to achieve a low level of HIV-DNA. Each additional year with suppressed HIV-RNA increased the likelihood of low level and decreased the likelihood of high level of HIV-DNA. Peak HIV-RNA higher than 5log10 was always associated with a decreased risk of low and an increased risk of high HIV-DNA. For patients with peak HIV-RNA lower than 5log10, past ART failure was associated with high level of HIV-DNA. Chronically HIV-infected patients with long-term suppressive ART can achieve low total HIV-DNA but one over six still presented HIV-DNA above 1000 copies/10 PBMCs despite long-term viral suppression.Keywords
This publication has 36 references indexed in Scilit:
- HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral TherapyClinical Infectious Diseases, 2014
- CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapyJournal of Clinical Virology, 2012
- Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradicationAIDS, 2010
- Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohortJournal of Antimicrobial Chemotherapy, 2010
- Early Levels of HIV‐1 DNA in Peripheral Blood Mononuclear Cells Are Predictive of Disease Progression Independently of HIV‐1 RNA Levels and CD4+T Cell CountsThe Journal of Infectious Diseases, 2005
- Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA levelAIDS, 2004
- Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapyAIDS, 2001
- Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapyProceedings of the National Academy of Sciences, 1997
- Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma ViremiaScience, 1997
- Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral TherapyScience, 1997